Advanced Proteome Therapeutics Corporation announced earnings results for the second quarter ended January 31, 2021. For the second quarter, the company announced net income was USD 27,541 compared to net loss of USD 113,837 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago. For the half year, net loss was USD 314,695 compared to USD 131,645 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 1 a year ago.